Gold Member Since 2011
Audited Supplier
Changzhou General Import and Export Corporation

Prl 8 53, Nootropics, Nootropics Powder manufacturer / supplier in China, offering Nootropics Powder Prl-8-53 Improve Memory CAS 51352-87-5, Sulbutiamine CAS: 3286-46-2 Smart Drugs Brain Improve Belong to Nootropics Sulbutiamine, Pyritinol Hydrochloride Pyritinol HCl Powder and so on.

(/ )

Supplier Homepage Product Steroids1 Testosterone Series Nootropics Powder Prl-8-53 Improve Memory CAS 51352-87-5

Nootropics Powder Prl-8-53 Improve Memory CAS 51352-87-5

FOB Price: US $110 / g
Min. Order: 100 g
Min. Order FOB Price
100 g US $110/ g
Get Latest Price
Production Capacity: 200kg/Month
Transport Package: 25kg/Drum or According to Customer′s Requiry
Payment Terms: L/C, T/T, D/P, Western Union, Paypal, Money Gram, Escrow

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: prl 8 53
  • Customized: Customized
  • Suitable for: Elderly, Adult
  • Purity: 98%
  • CAS No.: 51352-87-5
  • Appearance: White Crystalline Powder
  • MW.: 302.45
  • Trademark: CZG
  • Origin: Jiangsu, China(Mainland)
  • Powder: Powder and Finished
  • Certification: GMP, HSE, ISO 9001, USP, BP, GMP, USP
  • State: Powder and Finished
  • Product Name: Prl 8 53
  • Einecs No.: 200-366-3
  • Mf.: C20h30o2
  • Export Market: Global
  • Specification: USP
  • HS Code: 2801100000
Product Description
Nootropics Raw Powder Prl-8-53 Improve Memory CAS 51352-87-5

Name:PRL-8-53
Chemical name:Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate
Synonyms:PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride;m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester hydrochloride;Benzoic acid, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride
CAS 51352-87-5
MF:C18H22ClNO2
MW 319.82578
Dosage:
Subjects in human trials have been given up to 100 mg a day and did not appear to develop any negative side effects

Abstract
The effect of 3-(2-benzylmethylaminoethyl) benzoic acid methyl ester hydrochloride (PRL-8-53) on learning and on retention of verbal information in human subjects was investigated. Using the serial anticipation method under double-blind conditions it was found that PRL-8-53 causes slight improvement of acquisition. Retinetion of verbal information was found improved to a statistically significant degree (most P values better than 0.01, some better than 0.001). No significant changes were found for either visual reaction time or motor control after drug when compared with placebo values.

Description
PRL-8-53 (chemical name Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate) is a synthetic nootropic compound discovered in 1972 and patented in 1975 by the late Dr. Nikolaus Hansl, a neuropharmacologist at Creighton University in Omaha, Nebraska. Preliminary animal tests indicated that the compound was both safe and significantly nootropic, boosting avoidance learning in rodents with no adverse effects. But the real interest in PRL-8-53 was sparked by a 1978 study on human volunteers, which showed that a single dose of the compound could improve word retention scores by more than 200%.

HOW IT WORKS
PRL-8-53's exact mechanisms of action are not well understood, but it is generally believed to regulate the brain's production of and response to several crucial neurotransmitters. In his reports on human and animal studies Hansl indicated that PRL-8-53 potentiates dopamine, partially restricts production of serotonin, and enhances the brain's response to acetylcholine.

Though Hansl's research report on the 1978 human study suggests those actions, it does not clearly delineate the mechanism of action.The fact that older subjects saw the most nootropic benefit from taking the drug supports the concept that dopamine modulation plays a major role in PLR-8-53's effects. Up-regulating the normal age-related lessening of dopamine production that is associated with cognitive decline could have a significant positive impact on both learning and memory.

Dosage 
The only human study on PRL-8-53 was based on the ingestion of a single 5 mg dose. There is no data on the effectiveness or potential toxicity of any other dosage in humans.

SIDE EFFECTS
No adverse effects from a single 5 mg dose of PRL-8-53 were observed in the human study. Animal studies suggest that the compound has a high therapeutic threshold, but evidence is very limited because no comprehensive toxicity studies have been completed.

Related products :
 
Product nameCAS no:
Adrafinils63547-13-7
Mirodenafil862189-95-5
Noopept157115-85-0
Phenibut1078-21-3
Sulbutiamine3286-46-2
Sunifiram314728-85-3
DMHA (2-Aminoisoheptane)543-82-8
coluracetam135463-81-9
Fasoracetam110958-19-5

Other products :
Coluracetam 62613-82-5
Sunifiram 314728-85-3 
Unifiram 272786-64-8
Phenylpiracetam 7458-1-7
Pramiracetam Sulfate 72869-16-0
Pramiracetam 68497-62-1
Piracetam 7491-74-9
Oxiracetam 62613-82-5 
N-Methyl-D-aspartic Acid 6384-92-5 
Citicoline 987-78-0 
Phenibut 1078-21-3
Noopept 157115-85-0 
Alpha-GPC 28319-77-9
Aniracetam 72432-10-1
CDP-choline citicoline 987-78-0
Nefiracetam 77191-36-7
PRL-8-53 51352-87-5
IDR-21 22503-72-6
NSI-189 1270138-41-4
 
English NameCas No.Specification
Noopept157115-85-098%
Pramiracetam68497-62-198%
Piracetam 7491-74-998%
Oxiracetam62613-82-598%
Coluracetam135463-81-998%
Aniracetam72432-10-198%
Fasoracetam110958-19-5  98%
L-Theanine3081-61-610%-98%
Alpha-GPC28319-77-950%,98%
CDP-Choline146929-33-198%
Sulbutiamine3286-46-298%
Resveratrol501-36-050%,98%
5-HTP56-69-990%-98%
Prl-8-5351352-87-599%
Sunifiram314728-85-399%
IDRA-2122503-72-699%
Unifiram272786-64-899%
NSI-1891270138-40-399%

Contact methods:
sales05: Miss Emily
Sk-y- pe:maggie78481
 
Tel: +86 18861115105

Or click INQUIRY to contact me:))
 
Send your message to this supplier
Avatar
Miss Emily
skype:maggie78481
*From:
To: Miss Emily
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category